- Home
- MNPR vs MRT Comparison
MNPR vs MRT Comparison
Compare MNPR & MRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MNPR
- MRT
- Stock Information
- Founded
- MNPR 2014
- MRT 2018
- Country
- MNPR United States
- MRT Turkey
- Employees
- MNPR N/A
- MRT N/A
- Industry
- MNPR Biotechnology: Pharmaceutical Preparations
- MRT Rental/Leasing Companies
- Sector
- MNPR Health Care
- MRT Consumer Discretionary
- Exchange
- MNPR Nasdaq
- MRT Nasdaq
- Market Cap
- MNPR 113.5M
- MRT 117.0M
- IPO Year
- MNPR 2019
- MRT N/A
- Fundamental
- Price
- MNPR $30.68
- MRT $3.20
- Analyst Decision
- MNPR Strong Buy
- MRT
- Analyst Count
- MNPR 3
- MRT 0
- Target Price
- MNPR $27.33
- MRT N/A
- AVG Volume (30 Days)
- MNPR 93.6K
- MRT 177.2K
- Earning Date
- MNPR 11-08-2024
- MRT 01-01-0001
- Dividend Yield
- MNPR N/A
- MRT N/A
- EPS Growth
- MNPR N/A
- MRT N/A
- EPS
- MNPR N/A
- MRT N/A
- Revenue
- MNPR N/A
- MRT $18,953,502.00
- Revenue This Year
- MNPR N/A
- MRT N/A
- Revenue Next Year
- MNPR N/A
- MRT N/A
- P/E Ratio
- MNPR N/A
- MRT N/A
- Revenue Growth
- MNPR N/A
- MRT N/A
- 52 Week Low
- MNPR $1.55
- MRT $0.50
- 52 Week High
- MNPR $38.50
- MRT $3.55
- Technical
- Relative Strength Index (RSI)
- MNPR 76.63
- MRT 62.04
- Support Level
- MNPR $20.16
- MRT $3.05
- Resistance Level
- MNPR $25.97
- MRT $3.12
- Average True Range (ATR)
- MNPR 2.75
- MRT 0.32
- MACD
- MNPR 0.41
- MRT -0.02
- Stochastic Oscillator
- MNPR 90.25
- MRT 70.64
About MNPR Monopar Therapeutics Inc.
Monopar Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing proprietary therapeutics designed to extend life or improve the quality of life for cancer patients. The company's pipeline consists of Validive for the prevention of chemoradiotherapy-induced severe oral mucositis in oropharyngeal cancer patients, camsirubicin for the treatment of soft tissue sarcoma, a late-stage preclinical antibody, MNPR-101, for cancers and severe COVID-19 and an early-stage camsirubicin analog, MNPR-202, for various cancers.
About MRT Marti Technologies Inc.
Marti Technologies Inc is a mobility app, operating a fleet of over 48,000 e-mopeds, e-bikes, and e-scooters, serviced by proprietary software systems and IoT infrastructure.